Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combinatorial Gerotherapeutics for Healthspan Improvement
NCT07475546Phase 3Completed
- Sponsor
- AgelessRx
- Start
- Jul 2025
- Primary completion
- Apr 2026
- Modality
- Transdermal Patches, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus, naltrexone, liquid metformin (Aspargo Labs), nicotinamide adenine dinucleotide, glutathione in aging, sponsored by AgelessRx. Started Jul 2025; status: completed.
02
Drugs
sirolimusnaltrexoneliquid metformin (Aspargo Labs)nicotinamide adenine dinucleotideglutathione
03
Conditions
aging
Beyond the preview
Go deeper on NCT07475546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07475546.